About Kollol Pal
Form D filings for Revere Pharmaceuticals from 2019 to 2023 list Kollol Pal as director.
Kollol Pal first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Kollol Pal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kollol Pal works with at each company, as listed on that company's latest Form D.
Revere Pharmaceuticals Inc. · Form D, Jun 12, 2023
ML
Marc Lippman
Director
IS
Ian Silverman
President and Chief Executive Officer, director
JL
Jedd Levine
Executive officer and director